“ Clinical and economic aspects of the use of rituximab in non-Hodgkin’s lymphoma ”, Braz. J. Pharm. Sci., vol. 50, no. 3, pp. 445–455, Sep. 2014, doi: 10.1590/S1984-82502014000300002.